Brief: Centogene Sets Mission To Enable The Cure Of 100 Rare Diseases Within The Next 10 Years
June 22 (Reuters) - Centogene NV 39K.MU :
* CENTOGENE SETS MISSION TO ENABLE THE CURE OF 100 RARE
DISEASES
WITHIN THE NEXT 10 YEARS
* CENTOGENE NV - CLEAR PRIORITIES SET FOR THERAPEUTIC
DISEASE
AREAS, FOCUSING ON RARE NEUROLOGICAL (CNS) AND METABOLIC
DISORDERS
* CENTOGENE NV - MID-TERM TARGETS SET TO REACH 1 MILLION
PATIENTS
IN BIO/DATABANK AND 10 FULL DISEASE MODELS FOR RARE DISEASE
RESEARCH AND DEVELOPMENT PARTNERING
Source text for Eikon: ID:nGNX1hb6kq
Further company coverage: 39K.MU
((reuters.briefs@thomsonreuters.com;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice